Clinical Trials on Nerve Growth Factors in Canada

Total 814 results

ZandA Technologies, llc
KGK Science Inc.

Completed

The Efficacy and Safety of an Amino Acid Supplement in Adults

Healthy | Insulin-Like Growth Factor I

Canada
University of British Columbia
HopeLab Foundation; Social Sciences and Humanities Research Council of Canada; William T. Grant Foundation

Completed

Volunteering and Cardiovascular Risk in Adolescents

Cardiovascular Risk Factors

Canada
University of Monastir

Completed

Ramadan Fasting Effects in Patients With Cardiovascular Risk Factors

Cardiovascular Risk Factors | Fasting

Tunisia
Ottawa Hospital Research Institute

Completed

Shared Mental Health Care Linking Mental Health Services With Family Medicine Groups

Psychosocial Factors

Canada
Memorial University of Newfoundland

Recruiting

Sleep Duration and Quality in Children (Sleep-FAST)

Sleep | Food Habits | Lifestyle Factors

Canada
McMaster Children's Hospital

Unknown

Target Fortification of Breast Milk: How Often Breast Milk Needs to be Measured? (TFO2)

Postnatal Growth Disorder

Canada
McMaster Children's Hospital

Completed

Individualized Fortification of Breast Milk for Preterm Infants - A Pilot Study (IFO Pilot)

Postnatal Growth Disorder

Canada
University of British Columbia

Terminated

Sildenafil Therapy In Dismal Prognosis Early-Onset Intrauterine Growth Restriction (STRIDERCan)

Intrauterine Growth Restriction (IUGR) | Fetal Growth Restriction (FGR)

Canada
University of Manitoba
Johns Hopkins University; University Health Network, Toronto; University of California... and other collaborators

Recruiting

International Milk Composition (IMiC) Consortium (IMiC)

Maternal Health | Infant Growth | Infant Nutrition

Canada
McMaster Children's Hospital

Unknown

Individualized Fortification of Breast Milk (IFO)

Neurodevelopment | Postnatal Growth Disorder

Canada
University Health Network, Toronto
Sunnybrook Health Sciences Centre; MOUNT SINAI HOSPITAL

Recruiting

DAPAgliflozin Sodium Water glucosE EffecTs in Patients at High Cardiovascular Risk (DAPA-SWEET)

Cardiovascular Risk Factor

Canada
Laboratorios Ordesa
Universidad de Granada

Unknown

Effect of a New Infant Formula With Specific Ingredients (EARLY-TOLERA)

Infant Growth

Spain
Sunnybrook Health Sciences Centre

Completed

Relationship of Genes and Life Events to Blood Pressure

Hypertension | Psychosocial Factors

Canada
Heart Force Medical Inc.

Completed

Correlation Between the SPhENo-Cardiograph™, a Seismocardiograph Device, and GE Vivid Q, an Echocardiograph, for Known Systemic Timing Intervals (STI)

Cardiovascular Risk Factor

Canada
Ottawa Heart Institute Research Corporation

Completed

The Role of a Motion Sensor With Accompanying Web Application on Step Counts, Energy Balance, and Metabolic Markers in Nurses (WALK)

Cardiovascular Diseases | Cardiovascular Risk Factor

Canada
CHU de Quebec-Universite Laval
Laval University; Chaire Jeanne-et-Jean-Louis Lévesque en périnatalogie

Completed

Pre-Eclampsia And Growth Restriction: a Longitudinal Study (PEARL)

Preterm Birth | Preeclampsia | Severe Preeclampsia | Fetal Growth Restriction

Canada
Astellas Pharma Global Development, Inc.
Medivation LLC, a wholly owned subsidiary of Pfizer Inc.

Completed

A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer

Advanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)

United States, Belgium, Canada, Italy, Spain, United Kingdom
Amgen

Recruiting

A Study Evaluating Bemarituzumab in Solid Tumors With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression (FORTITUDE-301)

Solid Tumors

Canada, Korea, Republic of, Australia, Netherlands, United States, Israel, Austria, Spain, United Kingdom, France, Belgium, Japan, Czechia, Hungary, Poland, Brazil, Italy, Argentina, Denmark, Greece, Mexico, Switzerland, Romania, Finland and more
Hamilton Health Sciences Corporation
Southlake Regional Health Centre; Federal Economic Development Agency for Southern... and other collaborators

Completed

The DNA-Based Lifestyle Enhancement Trial (DNAble)

Health Behavior | Cardiovascular Risk Factor | Genetic Information

Canada
Emmanuel Bujold
Laval University; Thermo Fisher Scientific, Inc

Completed

Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening (PREDICTION2)

Preterm Birth | Preeclampsia | Fetal Growth Restriction | Intra Uterine Fetal Death

Canada
Saint Thomas Hospital, Panama

Unknown

Antiphospholipid Antibodies and Fetal Growth Restriction

Antiphospholipid Syndrome | Fetal Growth Restriction

Panama
McMaster University
St. Joseph's Healthcare Hamilton; Canadian Institutes of Health Research (CIHR) and other collaborators

Completed

Motivational Interviewing to Promote Healthy Behaviours in Young Adults (Motivate)

Obesity | Risk Factors

Canada
Louis Bherer
Canadian Institutes of Health Research (CIHR); The Montreal Health Innovations...

Recruiting

A Combined Multidomain Intervention to Prevent Cognitive Decline Associated With Cardiovascular Risk Factors. (ACTIONcR)

Aging | Cardiovascular Risk Factor

Canada
University of Calgary

Recruiting

Human Milk Fortification With Adjustable Versus Targeted Method (FAT)

Growth Failure

Canada
CHU de Quebec-Universite Laval
Canadian Institutes of Health Research (CIHR); Laval University

Completed

First-trimester Prediction of Preeclampsia (PREDICTION)

Preterm Birth | Preeclampsia | Severe Preeclampsia | Fetal Growth Restriction

Canada
McMaster University
Canadian Institutes of Health Research (CIHR)

Terminated

A Web-based Platform to Conduct Trials of mHealth Apps for Hypertension

Hypertension | Cardiovascular Risk Factor

Canada
CHU de Quebec-Universite Laval

Completed

Comparison of Doses of Acetylsalicylic Acid in Women With Previous History of Preeclampsia

Premature Birth | Pre-Eclampsia | Fetal Growth Retardation | Placental Insufficiency

Canada
Brock University
York University

Recruiting

Effects of Increased Greek Yogurt Consumption in Youth and Young Adult Athletes

Inflammation | Bone Growth Abnormal

Canada
Merck KGaA, Darmstadt, Germany
EMD Serono, a division of EMD Inc., Canada

Completed

A Canadian, Multi-centre, Observational Registry to Study Adherence and Long Term Outcomes of Therapy in Pediatric Subjects Using SAIZEN® Via Easypod™ Auto-injector for Growth Hormone Treatment (ECOS CAN)

Growth Disorders

Canada
Abbott Nutrition

Active, not recruiting

Infant Formula and Toddler Drink Feeding Study

Growth

United States
Ferring Pharmaceuticals
Ferring SAU

Completed

Adipocyte Function and Somtropin Deficiency (FAYDS)

Growth Hormone Deficiency

Spain
St. Boniface Hospital

Recruiting

Women's Advanced Risk-assessment in Manitoba (WARM)

Vascular Stiffness | Cardiovascular Risk Factor | Cardiovascular Disease (CVD)

Canada
Lawson Health Research Institute

Unknown

Evaluation of Use of Ultrasound for Greater Palatine Nerve Block and Inferior Alveolar Nerve Blocks: An Open Label Feasibility Study

Inferior Alveolar Nerve Block | Greater Palatine Nerve Block

Canada
Unity Health Toronto

Unknown

The Effect of Viscous Dietary Fibers on LDL-cholesterol

Hypercholesterolemia | Cardiovascular Risk Factor

Canada
University of British Columbia
Pediatric Orthopaedic Society of North America

Unknown

Diffusion MRI and Growth Plate Injuries: Pilot Study

Fracture

Canada
Institute for Clinical Evaluative Sciences
Heart and Stroke Foundation of Ontario; The Ontario Spor Support Unit; CorHealth... and other collaborators

Recruiting

Using Big Data to Conduct Innovative Cardiovascular Clinical Trials

Cardiovascular Diseases | Dyslipidemias | Cardiovascular Risk Factor

Canada
Centre for Addiction and Mental Health
The Hospital for Sick Children; University of Toronto; Trillium Health Centre; Medical...

Completed

Technology-Enabled Collaborative Care for Youth (TECC-Y)

Psychosis | Cardiovascular Risk Factor | Metabolic Disease

Canada
AstraZeneca

Completed

Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using Patients (GADES)

Risk Factors | Compliance | Gastroprotector Therapy

Spain
University of Manitoba
Unity Health Toronto; University of Toronto; Ontario Agency for Health Protection...

Unknown

An Urban Trail Network and Cardiovascular Disease: A Natural Experiment

Cardiovascular Diseases | Diabetes Mellitus | Cardiovascular Risk Factor

Canada
Hoffmann-La Roche

Terminated

A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy (Veronica)

Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer

Canada, United States, United Kingdom, Australia, Germany
Novo Nordisk A/S

Completed

Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years

Foetal Growth Problem | Small for Gestational Age

Spain
University of Alberta
Cross Cancer Institute

Completed

Therapeutic Resistance Group Exercise Training for Head & Neck Cancer Survivors (TARGET)

Head and Neck Neoplasms | Fatigue | Accessory Nerve Injury

Canada
Population Health Research Institute
Bristol-Myers Squibb; Pfizer; M-Health Solutions

Completed

Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder (ASSERT-III)

Hypertension | Elderly | Risk Factors for Atrial Fibrillation

Canada
Allan Kember
University of Michigan; Nova Scotia Health Authority; Grand Challenges Canada; Harvard... and other collaborators

Completed

Halifax PrenaBelt Trial

Sleep | Pregnancy | Fetal Growth Retardation | Infant, Very Low Birth Weight | Stillbirth | Infant, Small for Gestational Age | Fetal Hypoxia | Infant, Low Birth Weight

Canada
CHU de Quebec-Universite Laval

Completed

Effect of Low Dose Aspirin on Birthweight in Twins: The GAP Trial. (GAP)

Premature Birth | Fetal Growth Retardation | Preeclampsia | Infant, Very Low Birth Weight | Small for Gestational Age

Canada
John Sievenpiper

Not yet recruiting

Meta-analyses of Soy Protein and Its Food Sources for Cholesterol Reduction

Dyslipidemias | Cardiovascular Risk Factor | Dysglycemia

Canada
University of Toronto

Completed

Cardiovascular Health And Risk Modification in Family Health Teams (Multi-CHARM)

Hypertension | Diabetes | Hyperlipidemia | Cardiovascular Risk Factors

Canada
Epineuron Technologies Inc.

Completed

Feasibility Study of a Temporary Peripheral Nerve Stimulator

Nerve Injury

Canada
University of Alberta

Terminated

Neurometer vs Nerve Stimulator: Block Patients

Nerve Block Assessment

Canada
University of Alberta

Recruiting

The Effect of Pre-operative Electrical Stimulation on Peripheral Nerve Regeneration.

Peripheral Nerve Injuries | Sensory Deficit | Digital Nerve Lesion

Canada

Clinical Trials on Nerve Growth Factors in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saint Lucia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations